MedPath

Effect of Manjishthadi Churna and Chandraprabha vati in the management of Muta ashmari( Kidney Stone)

Phase 3
Conditions
Health Condition 1: N200- Calculus of kidney
Registration Number
CTRI/2024/04/065137
Lead Sponsor
Ch Brahm Prakash Ayurved Charak Sansthan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Age group between l8 to 60 years.

2.Size of calculi upto 10mm.

3.Irrespective of type of calculi.

4.Subjects who are ready to sign the informed consent.

5.Subjects who are not registered in any other research project.

6.Subjects who can take medicine orally.

Exclusion Criteria

1.Patient below 18 years and above 60 years.

2.Calculus with severe Obstructive hydronephrosis.

3.Obstructive calculi with severe infections.

4.Calculi with severe systemic disorders like Diabetes, Hypertension, CA, AIDS or any other known metabolic & endocrine disorders.

5.Calculi in pregnant women.

6.CBD and Gall bladder stone.

7.Subjects who are not ready to sign the informed consent.

8.Subjects who are registered in any other research project.

9.Subjects who cannot take medicine orally

10.Patients Suffering from any severe illness.

11.Impaired renal function, Renal Cyst, more than 3 calculi or no. not mentioned.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The efficacy of the treatment will be assessed on the basis of reduction in size of calculi in USG. <br/ ><br> <br/ ><br>Timepoint: 30 days <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Improvised Routine & Microscopic analysis of urine. <br/ ><br> <br/ ><br>Improvement in the quality of life. <br/ ><br> <br/ ><br>Improvised sign & symptoms of Mutrashmari: <br/ ><br>Pain <br/ ><br>Urine hesitancy <br/ ><br>Hematuria <br/ ><br>Improper urine stream <br/ ><br>Pain during running, <br/ ><br>Over riding, swimming, horse riding & walking. <br/ ><br>Timepoint: 30 day
© Copyright 2025. All Rights Reserved by MedPath